Nanoparticle-based drug delivery systems: What can they really do in vivo? [version 1; referees: 3 approved]

In the past few decades, there has been explosive growth in the construction of nanoparticle-based drug delivery systems (NDDSs), namely nanomedicines, owing to their unique properties compared with traditional drug formulations. However, because of a variety of challenges, few nanomedicines are on...

Full description

Bibliographic Details
Main Authors: Yi-Feng Wang, Lu Liu, Xue Xue, Xing-Jie Liang
Format: Article
Language:English
Published: F1000 Research Ltd 2017-05-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/6-681/v1

Similar Items